Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Curing hepatitis C virus (HCV) after organ transplantation: Increased risk of rejection following HCV elimination.

Transplant infectious disease : an official journal of the Transplantation Society - 1 Feb 2018

Kasarala George, Choi Steve, Lopez Katie, Britt Rachel B, Boatright Colleen, Tillmann Hans L

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Graft Rejection
Share to Hepacivirus
Share to Hepatitis C

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Liver Transplantation

Share to Monitoring, Physiologic

Share to Recurrence

Source

Identifiers

PMID: 29064152
DOI: 10.1111/tid.12796

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Curing hepatitis C virus (HCV) after organ transplantation: Increased risk of rejection following HCV elimination.PMID 29064152Read ↗

Management of hepatitis C after transplantation: a long way from success.Semantic proximity Read ↗

Hepatitis C Virus Eradication in Kidney Transplant Recipients: A Single-Center Experience in Portugal.Semantic proximity Read ↗

HCV eradication in chronic kidney disease: ready for prime time?Semantic proximity Read ↗

Recurrent hepatitis C following liver transplant: diagnosis, natural history, and therapeutic options.Semantic proximity Read ↗

Hepatitis C treatment in patients on the liver transplant waiting list.Semantic proximity Read ↗

Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study.Semantic proximity Read ↗

Transplantation for hepatitis C: good news and bad news.Semantic proximity Read ↗

Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient.Semantic proximity Read ↗

The Moral Necessity to Increase Access to HCV+ Transplants With Early Treatment for HCV-naive Patients.Semantic proximity Read ↗

Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial.Semantic proximity Read ↗

Hepatitis C virus in the transplant setting.Semantic proximity Read ↗

Antiviral treatment with sofosbuvir and simeprevir in a kidney transplant recipient with HCV-decompensated cirrhosis: viral eradication and removal from the liver transplant waiting list.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.